Inscripta® Appoints Kristala Prather, PhD to its Board of Directors
January 5, 2022
BOULDER, Colo. -- Inscripta, Inc., The Digital Genome Engineering Company, today announced that it has appointed Kristala Prather, PhD, to serve on its Board of Directors. Dr. Prather is currently the Arthur D. Little Professor and Executive Officer of the Department of Chemical Engineering at MIT. “We are very excited to have Kris join our board. [...]
January 5, 2022
Florida, USA – BioTools, the pioneer in vibrational circular dichroism (VCD) technology and provider of proprietary instrumentation and analytical services for structure elucidation of chiral molecules, announces a collaboration with Schrödinger, Inc., whose physics-based software platform is transforming the way therapeutics and materials are discovered, to help chemists expedite the determination of the critical three-dimensional [...]
January 5, 2022
Akoya’s powerful new PhenoCycler™-Fusion system combined with Bio-Techne’s proven and established RNAScope® technology will enable comprehensive spatial phenotyping of RNA and protein biomarkers MARLBOROUGH, Mass. and MINNEAPOLIS -- Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, and Bio-Techne (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research [...]
January 5, 2022
Bio-Techne's proven and established RNAScope® technology combined with Akoya's powerful new PhenoCycler™-Fusion system will enable comprehensive spatial phenotyping of RNA and protein biomarkers MINNEAPOLIS and MARLBOROUGH, Mass. -- Bio-Techne (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, and Akoya Biosciences, Inc., (NASDAQ: AKYA), The [...]
New scientific advisory Board at Qlucore
January 5, 2022
Qlucore, provider of intuitive bioinformatics software for research and precision and companion diagnostics, announces the creation of a Scientific Advisory Board (SAB), consisting of five members, chaired by Carl-Johan Ivarsson, CEO of Qlucore. The SAB includes two of Qlucore’s founders; Thoas Fioretos and Magnus Fontes and three independent senior and renowned scientists and industry experts. [...]
Biotium Introduces Unique Super-Sensitive RNA Prestain Loading Dye
January 5, 2022
EMBER500™ RNA Prestain Loading Dye allows single-step denaturing, loading, and bright RNA staining on regular agarose gels Fremont, CA – Life Science Newswire – Biotium, inventor of the popular GelRed® and GelGreen® DNA gel stains, announces the release of EMBER500™ RNA Prestain Loading Dye. This novel prestain loading dye is much more sensitive than conventional [...]
Gator Bio Announce Gator™ Part11 Software for Biologics Development in Biopharma
January 5, 2022
PALO ALTO, Calif. -- Drug makers, biotech companies, biologics developers and CROs will now have the much-needed 21 CFR Part11-compliant software for their GatorPrime and GatorPlus Biolayer Interferometry systems (BLI). The software announced today significantly enhances Gator Bio's BLI solution for biologics development, which includes application-specific biosensors, Gator™ GatorOne Software and BLI systems. "Our customers, in no uncertain terms, had told us [...]
Thermo Fisher Scientific Completes Acquisition of PeproTech, a Leader in Recombinant Proteins
January 5, 2022
Increases capabilities serving the high growth cell and gene therapy market WALTHAM, Mass. -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and PeproTech, Inc., a leading developer and manufacturer of recombinant proteins, today announced that Thermo Fisher completed its acquisition of PeproTech on December 30, 2021 for a total cash purchase [...]
PacBio and Care4Rare Consortium Collaborate on Rare Disease Research Study
January 5, 2022
MENLO PARK, Calif. -- PacBio, a leading provider of high-quality, long-read sequencing platforms, and the Care4Rare Canada Consortium (Care4Rare) announce today they are collaborating to study some of the most complex unexplained rare disease cases within Canada. Care4Rare, led out of the CHEO Research Institute affiliated with the University of Ottawa, includes 21 academic sites across [...]
Cytek® Biosciences Expands Fremont Headquarters, Tripling Its Manufacturing Capacity
January 5, 2022
Operations to Accommodate Increasing Demand for Cell Analysis Solutions FREMONT, Calif. -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that it has opened a new facility in Fremont, California – tripling its current manufacturing capacity in order to meet growing global demand for cell analysis solutions. In addition to the [...]

